Enveric Biosciences, Inc. · NASDAQ:ENVB
Mitchell P. Kopin's stake in Enveric Biosciences, Inc. fell to 4.99% (Schedule 13G)
Event Jan 27, 2026 · Filed Feb 2, 2026
Mitchell P. Kopin's stake in Enveric Biosciences, Inc. fell to 4.99%, 71,246 shares, as a passive investor on Jan 27, 2026. Filed Feb 2, 2026 (Schedule 13G).
- Stake
- 4.99%
- Shares
- 71,246
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Mitchell P. Kopin | 4.99% | 71,246 |
| Daniel B. Asher | 4.99% | 71,246 |
| Intracoastal Capital LLC | 4.99% | 71,246 |
Source
Related
- Enveric Biosciences, Inc.
- Mitchell P. Kopin
- Enveric Biosciences, Inc. shareholders
- Schedule 13G · Mitchell P. Kopin · Dec 17, 2025
- Schedule 13G · Mitchell P. Kopin · Sep 24, 2025
- Schedule 13G · Mitchell P. Kopin · Feb 5, 2025
- Schedule 13G/A · Lind Global Fund III LP · Aug 14, 2026
- Schedule 13G · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Ayrton Capital LLC · Aug 13, 2026
- Form 4 · Coveney Kevin Michael · Jun 3, 2026
- Form 4 · Tucker Joseph Edward · Jun 3, 2026